Abstract:Molecular imaging includes proteomic, metabolic, cellular biologic process, and genetic imaging. In a narrow sense, molecular imaging means genetic imaging and can be called molecular-genetic imaging. Imaging reporter genes play a leading role in molecular-genetic imaging. There are 3 major methods of molecular-genetic imaging, based on optical, MRI, and nuclear medicine modalities. For each of these modalities, various reporter genes and probes have been developed, and these have resulted in successful transitions from bench to bedside applications. Each of these imaging modalities has its unique advantages and disadvantages. Fluorescent and bioluminescent optical imaging modalities are simple, less expensive, more convenient, and more user friendly than other imaging modalities. Another advantage, especially of bioluminescence imaging, is its ability to detect low levels of gene expression. MRI has the advantage of high spatial resolution, whereas nuclear medicine methods are highly sensitive and allow data from small-animal imaging studies to be translated to clinical practice. Moreover, multimodality imaging reporter genes will allow us to choose the imaging technologies that are most appropriate for the biologic problem at hand and facilitate the clinical application of reporter gene technologies. Reporter genes can be used to visualize the levels of expression of particular exogenous and endogenous genes and several intracellular biologic phenomena, including specific signal transduction pathways, nuclear receptor activities, and protein-protein interactions. This technique provides a straightforward means of monitoring tumor mass and can visualize the in vivo distributions of target cells, such as immune cells and stem cells. Molecular imaging has gradually evolved into an important tool for drug discovery and development, and transgenic mice with an imaging reporter gene can be useful during drug and stem cell therapy development. Moreover, instrumentation improvements, the identification of novel targets and genes, and imaging probe developments suggest that molecular-genetic imaging is likely to play an increasingly important role in the diagnosis and therapy of cancer.

Progress in Imaging in Vivo Based on Microrna

Molecular Imaging of Micrornas

Genetically Encoded Reporter Genes for MicroRNA Imaging in Living Cells and Animals

Recent Advances in DNA‐Based Nanoprobes for In vivo MiRNA Imaging

[Research Progress of Radionuclide Tracing in Small Interference RNA Imaging in Vivo].

In Vivo Imaging of RNA Interference.

Spatiotemporally Controllable MicroRNA Imaging in Living Cells via a Near-Infrared Light-Activated Nanoprobe

Stimuli-responsive probes for amplification-based imaging of miRNAs in living cells

Recent Advance in Detection of MicroRNA in Mammalian Animals

In Situ Single-Molecule Imaging of MicroRNAs in Switchable Migrating Cells under Biomimetic Confinement.

In Vivo Stem Cell Imaging

Near‐Infrared Fluorescence Imaging of miRNA Using a Transmembrane Polypeptide‐Based Genetic Reporter

A DNA machine-based magnetic resonance imaging nanoprobe for in vivo microRNA detection

Nanodevice-based imaging of miRNA in vivo by eliminating blood interference

Activated DNA Nanoprobes for Biosensing and Precision Imaging of MicroRNA in Living Cells

Live Cell Microrna Imaging Using Exonuclease Iii-Aided Recycling Amplification Based on Aggregation-Induced Emission Luminogens

Noninvasive Visualization of Microrna-155 in Multiple Kinds of Tumors Using a Radiolabeled Anti-Mirna Oligonucleotide

Molecular-genetic imaging based on reporter gene expression

Research progress of live-cell RNA imaging techniques

Precise Spatial Imaging of Micrornas Distribution from Single Living Cells

Harnessing PUF-Based Reporters for Noninvasive Imaging of the MicroRNA Dynamics in Differentiation